- Mylan CEO “frustrated” by own price gouging but doesn’t lower EpiPen price http://arstechnica.co.uk/science/2016/08/mylan-ceo-frustrated-by-own-price-gouging-but-doesnt-lower-epipen-price/ 40 comments worldnews
Linked pages
- Martin Shkreli Weighs in on EpiPen Scandal, Calls Drug Makers 'Vultures' http://www.nbcnews.com/business/consumer/martin-shkreli-weighs-epipen-scandal-calls-drug-makers-vultures-n634451 315 comments
- Rage mounts against pharma corp. that jacked cost of life-saving EpiPen by 400% | Ars Technica http://arstechnica.com/science/2016/08/rage-mounts-against-pharma-corp-that-jacked-cost-of-life-saving-epipen-by-400/ 197 comments
- $750/pill pharma company reverses decision to lower drug price | Ars Technica http://arstechnica.com/science/2015/11/750pill-pharma-company-reverses-decision-to-lower-drug-price/ 50 comments
- US unveils charges against KickassTorrents, names two more defendants | Ars Technica http://arstechnica.com/tech-policy/2016/08/us-unveils-charges-against-kickasstorrents-names-two-more-defendants/ 4 comments
- Controversial CEO in the hot seat over EpiPen price hikes https://www.statnews.com/2016/08/24/epipen-mylan-bresch/ 0 comments
Related searches:
Search whole site: site:arstechnica.co.uk
Search title: Mylan CEO “frustrated” by own price gouging but doesn’t lower EpiPen price | Ars Technica
See how to search.